Skip to content

Member

Manuela RIPA

EPP · Germany

Group
EPP PPE
Country
Germany
Roll-call participation
87.9 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
83.5 %ⓘ of 5 211 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
ÖDP Ökologisch-Demokratische Partei
In office
Since 16 Jul 2024
Against clear line
772 of 4 985 votesⓘ
Committees
CULT, ENVI (substitute), FEMM (substitute), SANT (substitute)
Member id
206158
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

87.9 %

5 211 of 5 928 roll calls while in office

EPP median: 89.9 % (−2.0 pts)

Chamber median: 90.2 %

With majority line ⓘ

83.5 %

4 353 of 5 211 votes where their group had a line

EPP median: 93.6 % (−10.1 pts)

Against clear line ⓘ

15.5 %

772 of 4 985 votes where their group had a clear line

583 opposite (for ↔ against), 174 abstained against the line, 15 voted for or against when the line was to abstain

Abstention ⓘ

3.9 %

203 of 5 211 votes cast

Participation 87.9 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Manuela RIPA87.9 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 83.5 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Manuela RIPA83.5 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: For Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: For Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: Against ≠ groupMajority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: For ≠ groupMajority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: For ≠ groupMajority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: For ≠ groupMajority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: Against ≠ groupMajority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: Against ≠ groupMajority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: Against Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: For ≠ groupMajority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 20 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202420
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202420
22 Oct 20241010
23 Oct 2024129128
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 20241818
27 Nov 20241111
28 Nov 20245757
17 Dec 2024130
18 Dec 2024330
19 Dec 2024450
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254541
10 Feb 202511
11 Feb 20253232
12 Feb 20251010
13 Feb 20253030
10 Mar 202522
11 Mar 202599
12 Mar 2025228225
13 Mar 20252424
31 Mar 202533
1 Apr 20253535
2 Apr 2025251249
3 Apr 20256261
5 May 202554
6 May 20251010
7 May 2025220218
8 May 2025103101
21 May 202522
22 May 20255351
16 Jun 202522
17 Jun 20254141
18 Jun 20259190
19 Jun 20258786
7 Jul 202511
8 Jul 20255555
9 Jul 2025134133
10 Jul 20253636
8 Sept 202511
9 Sept 2025101100
10 Sept 20253434
11 Sept 20256969
6 Oct 202522
7 Oct 202555
8 Oct 20255555
9 Oct 20256565
20 Oct 202530
21 Oct 20251313
22 Oct 2025186184
23 Oct 20255555
13 Nov 2025267265
24 Nov 202530
25 Nov 2025750
26 Nov 20251000
27 Nov 20251250
15 Dec 202540
16 Dec 2025660
17 Dec 2025430
18 Dec 2025420
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141139
24 Feb 2026430
9 Mar 202610
10 Mar 2026197193
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202620
28 Apr 2026225225
29 Apr 2026296296
30 Apr 20266868
18 May 202640
19 May 202633
20 May 20269695
21 May 20269898
15 Jun 202620
16 Jun 20264040
17 Jun 2026127127
18 Jun 20267777
6 Jul 202622
7 Jul 20267271
8 Jul 2026144143
9 Jul 20266767
14 Sept 202610
15 Sept 2026155154
16 Sept 20268078
17 Sept 202612454

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Sirpa PIETIKÄINEN EPPFinland86 % of 4 456 shared89 %
Isabel WISELER-LIMA EPPLuxembourg85 % of 4 989 shared89 %
Sandra KALNIETE EPPLatvia84 % of 4 877 shared89 %
Martine KEMP EPPLuxembourg84 % of 4 191 shared89 %
Liesbet SOMMEN EPPBelgium84 % of 5 066 shared89 %
Aura SALLA EPPFinland84 % of 4 473 shared89 %
Rasa JUKNEVIČIENĖ EPPLithuania84 % of 4 214 shared89 %
Willemien KONING EPPNetherlands84 % of 1 898 shared89 %
Niels GEUKING EPPGermany84 % of 5 158 shared89 %
Wouter BEKE EPPBelgium84 % of 5 028 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Martin HOJSÍK RenewSlovakia87 % of 4 800 shared82 %
Veronika CIFROVÁ OSTRIHOŇOVÁ RenewSlovakia87 % of 4 081 shared82 %
Ľudovít ÓDOR RenewSlovakia87 % of 4 892 shared82 %
Lucia YAR RenewSlovakia87 % of 5 156 shared82 %
Michal WIEZIK RenewSlovakia87 % of 5 023 shared82 %
Yvan VEROUGSTRAETE RenewBelgium86 % of 3 809 shared82 %
Valérie HAYER RenewFrance86 % of 5 028 shared82 %
Dan BARNA RenewRomania86 % of 4 593 shared82 %
Dainius ŽALIMAS RenewLithuania86 % of 4 818 shared82 %
Ľubica KARVAŠOVÁ RenewSlovakia86 % of 3 262 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Culture and EducationCULT CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute12 Dec 2024now
Committee on Public HealthSANT CommitteeSubstitute29 Apr 2025now
Delegation to the Cariforum-EU Parliamentary CommitteeDCAR Joint parliamentary committeeSubstitute19 Sept 2024now
Delegation for relations with MercosurDMER DelegationMember19 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember2 Jun 2026now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupVice-chair8 Jan 2025now

Show all 12 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedShadow rapporteurCULT18 Sept 2026
No dossier namedOfficial delegationCULT8 Sept 2026
No dossier namedOfficial delegationENVI8 Sept 2026
Psychosocial risks, stress and mental health at workShadow rapporteur for an opinionSANT14 Apr 2026
Need for a long-term EU development cooperation strategy to face challenges in education in developing countriesShadow rapporteur for an opinionCULT14 Apr 2026
No dossier namedOfficial delegationENVI21 Oct 2025
No dossier namedOfficial delegationCULT18 Sept 2025
The EU strategic objectives for the 20th meeting of the Conference of the Parties to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), to be held in to be held in Samarkand, Uzbekistan, from 24 November to 05 December 2025RapporteurENVI12 May 2025
No dossier namedOfficial delegationCULT8 Apr 2025
INI for a new vision for the European Universities AlliancesShadow rapporteur for an opinionCULT4 Feb 2025

Show all 13 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

19 contributions recorded; 1 on behalf of their group; 34 minutes of speaking time.

Show all 19 recent contributions

Questions and motions, 45

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Circular Economy Act: regulatory barriers to secondary raw materials E-10-2026-003654Written questionwith 29 co-authorsNot yet answered
21 Jul 2026Implementation of the recommendations of the Commission’s Special Panel on children in the digital world E-10-2026-003064Written questionwith 13 co-authors11 Sept 2026
13 Jul 2026Risk of extinction of the Pityusan wall lizard (Podarcis pityusensis) due to the spread of invasive snakes, and the adequacy of current quarantine measures E-10-2026-002870Written questionwith 10 co-authors1 Sept 2026
30 Jun 2026Follow-up to question for written answer E-001083/2025 on menstrual products: transparency and health risks E-10-2026-002698Written questionwith 43 co-authors18 Sept 2026
29 Jun 2026Scrutiny of hunting trophy imports into the EU E-10-2026-002689Written questionwith 8 co-authors25 Aug 2026
23 Jun 2026Harmonised charging and battery systems for light means of transport (LMTs) E-10-2026-002584Written question1 Sept 2026
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
9 Jun 2026Strengthening prevention, mental well-being and healthy ageing through improved hearing health E-10-2026-002380Written questionwith 15 co-authors21 Aug 2026
4 Jun 2026Revision of Regulation (EC) No 1099/2009 and phase-out of CO₂ stunning of pigs E-10-2026-002317Written questionwith 12 co-authors21 Aug 2026
12 May 2026Stakeholder involvement and evidence-based decision-making regarding the Fur Free Europe citizens’ initiative E-10-2026-001966Written questionwith 11 co-authors9 Jul 2026

Show all 45 questions and motions

Amendments tabled in committee, 31

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ533
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ534
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ531
24 Jun 2026Establishing the Union support for internal security for the period from 2028 to 2034 LIBE-AM-790119 LIBE4
19 Jun 2026Establishing the 'AgoraEU' programme for the period 2028-2034, and repealing Regulations (EU) 2021/692 and (EU) 2021/818 CJ65-AM-790057 CJ6521
19 Jun 2026Establishing the 'AgoraEU' programme for the period 2028-2034, and repealing Regulations (EU) 2021/692 and (EU) 2021/818 CJ65-AM-790058 CJ657

Show all 31 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Manuela RIPA”. Member record. memberId 206158. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/206158?page=77&rows=all&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/206158. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/206158?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-206158,
  author = {{EU Parl Watch Research}},
  title = {{Manuela RIPA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/206158?page=77&rows=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/206158?page=77&rows=all&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 206158. Official source: https://www.europarl.europa.eu/meps/en/206158. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}